Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Peninsula Pharmaceuticals postpones potential $80.5mm IPO

Executive Summary

Peninsula Pharmaceuticals (anti-infectives) has postponed its February 2003 IPO proposal in which it had hoped to raise $60-80.5mm by offering 5.75mm shares priced at $12-14 each. The company originally filed in December 2002, hoping to raise $86.25mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • IPO

Related Companies